Timeline:	1983	Ash Medical Systems, Inc (“AMS”) founded by Dr. Stephen R. Ash and Robert B. Truitt to develop a home hemodialysis system
AMS creates spin off company, HemoCleanse, Inc (“HCI”), to develop new liver dialysis system and technology	1989
	1997	HemoCleanse, Inc purchases AMS to consolidate assets and develop vascular access technologies
HemoCleanse, Inc creates spin off company, Renal Solutions, Inc, ("RSI") to commercialize home hemodialysis system	2000
	2003	AMS is renamed Ash Access Technology, Inc. and is spun off from HemoCleanse, Inc. in order to commercialize vascular access technologies
Ash Access Technology, Inc. begins pivotal clinical trial on Zuragen™	2006
	2007	Received FDA approval for Centros™. Strategic partnership for Centros™ initiated with AngioDynamics, Inc.
AZEPTIC Trial completed for Zuragen™ Injection. Human "pilot" studies completed with ZuraPrep™	2008

Product Development:

• Column Disc
  peritoneal dialysis (PD) catheter
• Y-Tech
  peritoneoscopic system PD
• Cal-Carb HD
  oral calcium carbonate, phosphate binder
• SmartChart
  electronic clinical notation system
• CFC
  capillary filtrate collector, sub-q catheter
• BioLogic-HD
  home hemodialysis system
• BioLogic DT
  liver dialysis machine
• ThermoChem-HT
  intraperitoneal hyperthermia system
• Ash Advantage
  peritoneal dialysis (PD) catheter
• Ash Split-Cath
  chronic tunneled hemodialysis catheter
• DuoSplit
  acute hemodialysis catheter
• HC-10
  high flow single lumen catheter for liver dialysis
• Allient
  home hemodialysis system (by spin-off RSI)
• Centros™
  chronic tunneled hemodialysis catheter (strategic commercial partnership with Angiodynamics, Inc.)